Index.php
From Kokorodatabase
| Line 1: | Line 1: | ||
| - | A | + | March 31, 2007, Milan A recent study conducted by the scientists of Istituto di Ricerche Farmacologiche Mario Negri (IRFMN) in Milan, Italy showed that drinking coffee will help reduce the possibility of liver cancer. Led by Francesca Bravi, all published data was combined by the team to find the link between espresso drinking and hepatocellar carcinoma (HCC). HCC is really a primary cancer of the liver. Liver cancer could be the third largest cause of cancer deaths around the world, just behind lung and stomach cancer. At the least 11 reports that were done in southern Europe and Japan were the foundation of the IRFMN research. |
| - | + | The IRFMN study was a meta-analysis of published reports on HCC that included just how much coffee people had taken. All published data was combined by researchers to obtain a standard quantitative estimate of the relationship between coffee intake and HCC development. | |
| - | + | The results showed that coffee drinkers have at least 41 % reduced total of HCC risk when compared with those who never consumed coffee. The beneficial ramifications of coffee consumption were extremely progressive in reports that were done in southern Europe, commonly drank, and from Japan, where coffee drinking is less regular, and in subjects with chronic liver diseases | |
| - | + | Laboratory and animal studies have shown that some substances in coffee may become blocking agents that work by reacting with enzymes involved in carcinogenic cleansing. Coffee is really a component of coffee that has demonstrated an ability to give beneficial effects on the liver enzymes and other enzymes of the body. Coffee consumption in addition has been connected to reduced risks of liver diseases and cirrhosis, both of which can lead to liver cancer. | |
| - | + | Individual studies also show that caffeine might worsen the observable symptoms of menopause or intensify the effects of specific medicines. On another hand, heavy caffeine consumption could cause miscarriage. Other animal studies show that skin treatment added with caffeine may reduce the risk of skin cancer in mice. | |
| - | + | The authors note that it requires to be repeated in other groups, whilst the research found a significant relationship between drinking coffee and having less liver cancer. The authors remember that despite the persistence of the results of the research, it's difficult to uncover causal relationship on the basis of the observational studies alone. It could be that people with intestinal tract disorders, including liver problems, obviously reduce their coffee consumption, although elimination of coffee is not routinely recommended. | |
| - | + | The authors remember that it takes to be repeated in other organizations to be much more concrete, whilst the research found a significant relationship between drinking coffee and having less liver cancer. | |
| - | + | The IRFMN researchers remember that the notion of coffee consumption was entirely predicated on individuals reporting, even though the recollection of coffee drinking has been shown to be appropriate. Factors like hepatitis B and C, cirrhosis, social class indictors, alcohol use, and smoking suggests that these elements didn't influence the outcomes of the reports. | |
| - | + | The outcomes out of this research may give some evidence of a match up between liver cancer and coffee consumption. However, the interpretation of this research remains unclear because of lack of long-term evaluation of the results of the said study. | |
| - | + | Research : | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Revision as of 02:07, 5 January 2013
March 31, 2007, Milan A recent study conducted by the scientists of Istituto di Ricerche Farmacologiche Mario Negri (IRFMN) in Milan, Italy showed that drinking coffee will help reduce the possibility of liver cancer. Led by Francesca Bravi, all published data was combined by the team to find the link between espresso drinking and hepatocellar carcinoma (HCC). HCC is really a primary cancer of the liver. Liver cancer could be the third largest cause of cancer deaths around the world, just behind lung and stomach cancer. At the least 11 reports that were done in southern Europe and Japan were the foundation of the IRFMN research.
The IRFMN study was a meta-analysis of published reports on HCC that included just how much coffee people had taken. All published data was combined by researchers to obtain a standard quantitative estimate of the relationship between coffee intake and HCC development.
The results showed that coffee drinkers have at least 41 % reduced total of HCC risk when compared with those who never consumed coffee. The beneficial ramifications of coffee consumption were extremely progressive in reports that were done in southern Europe, commonly drank, and from Japan, where coffee drinking is less regular, and in subjects with chronic liver diseases
Laboratory and animal studies have shown that some substances in coffee may become blocking agents that work by reacting with enzymes involved in carcinogenic cleansing. Coffee is really a component of coffee that has demonstrated an ability to give beneficial effects on the liver enzymes and other enzymes of the body. Coffee consumption in addition has been connected to reduced risks of liver diseases and cirrhosis, both of which can lead to liver cancer.
Individual studies also show that caffeine might worsen the observable symptoms of menopause or intensify the effects of specific medicines. On another hand, heavy caffeine consumption could cause miscarriage. Other animal studies show that skin treatment added with caffeine may reduce the risk of skin cancer in mice.
The authors note that it requires to be repeated in other groups, whilst the research found a significant relationship between drinking coffee and having less liver cancer. The authors remember that despite the persistence of the results of the research, it's difficult to uncover causal relationship on the basis of the observational studies alone. It could be that people with intestinal tract disorders, including liver problems, obviously reduce their coffee consumption, although elimination of coffee is not routinely recommended.
The authors remember that it takes to be repeated in other organizations to be much more concrete, whilst the research found a significant relationship between drinking coffee and having less liver cancer.
The IRFMN researchers remember that the notion of coffee consumption was entirely predicated on individuals reporting, even though the recollection of coffee drinking has been shown to be appropriate. Factors like hepatitis B and C, cirrhosis, social class indictors, alcohol use, and smoking suggests that these elements didn't influence the outcomes of the reports.
The outcomes out of this research may give some evidence of a match up between liver cancer and coffee consumption. However, the interpretation of this research remains unclear because of lack of long-term evaluation of the results of the said study.
Research :
